Serie de Casos Retrospectiva de las Características Clínicas, del Manejo y Resultados de los Pacientes con COVID-19 en hospitales privados de la región metropolitana en la República de Panamá
[Clinical Characteristics, Management and Outcomes of patients with COVID-19 in private hospitals in the Republic of Panama, 2020]Descargas
Resumen
Introducción: El 9 de marzo de 2020 se confirma el primer caso de COVID-19 en la República de Panamá. Según el reporte #46 de Panamá emitido por la OPS el 26 de enero de 2021, Panamá es el segundo país de las Américas con más alta incidencia después de Estados Unidos.
Métodos: El diseño del estudio es observacional retrospectivo. En este estudio participaron 140 pacientes de 3 instituciones privadas localizadas en el área metropolitana de la República de Panamá.
Resultados: De la muestra, 65.71% eran hombres y 34.29% eran mujeres, 72 (51.43%) pacientes fueron hospitalizados. La edad media fue de 48.39 años. El 49% de los pacientes presentaron antecedentes personales patológicos, el más común fue hipertensión arterial (63.27%). Los síntomas más frecuentes encontramos fiebre (71.43%), tos (61.43%), fatiga (50.71%) y disnea (32.86%). Del total de pacientes, 55.71% recibió tratamiento intrahospitalario, 11.51% fue admitido a UCI, 9.29% sufrió complicaciones y las más frecuente fue falla respiratoria (61.54%). De los medicamentos utilizados en ese periodo de tiempo lo más comúnmente usado fue la hidroxicloroquina (91.03%) y la azitromicina (84.62%).
Conclusiones: Se encontraron resultados similares a estudios descriptivos realizados en distintos países con modelos similares al nuestro.
Abstract
Introduction: The first case of COVID-19 in the Republic of Panama was confirmed on March 9 2020. In the Panama #46 report issued by PAHO on January 26, 2021, Panama was the second country in the Americas with the highest incidence of COVID-19 after the United States.
Methods: The design of the study is a retrospective observational study of 140 patients from 3 private hospitals located in the metropolitan area of the Republic of Panama.
Results: Of the sample, 65.71% were men and 34.29% were women, 72 (51.43%) patients were hospitalized. The median age was 48.39 years. 49% of the patients presented a pathological personal history, the most common was arterial hypertension (63.27%). Of the sample, 65.71% were men and 34.29% were women, 72 (51.43%) patients were hospitalized. The average age was 48.39 years. 49% of patients had a pathological personal history where high blood pressure was the most frequent (63.27%). The most common symptoms were fever (71.43%), cough (61.43%), fatigue (50.71%) and dyspnea (32.86%). Of the total number of patients, 55.71% received in-hospital treatment, 11.51% were admitted to the ICU, 9.29% suffered complications, the most frequent was respiratory failure (61.54%). Of the drugs used in that time period, the most commonly used were hydroxychloroquine (91.03%) and azithromycin (84.62%).
Conclusions: Similar results were found to descriptive studies carried out in different countries with models similar to ours.
Citas
[1] Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet [Internet]. 2020 Mar 28 [cited 2021 Mar 11];395(10229):1054-62. Available from: https://doi.org/10.1016/ DOI: https://doi.org/10.1016/S0140-6736(20)30566-3DOI: https://doi.org/10.1016/S0140-6736(20)30566-3
[2] World Health Organization. WHO Timeline - COVID-19. Who. 2020;
[3] Ministerio de Salud de Panamá. Panamá confirma primer caso de COVID-19 | Ministerio de Salud de la República de Panamá [Internet]. Ministerio de Salud de Panamá (MINSA) 2020. Available from: http://minsa.gob.pa/noticia/panama-confirma-primer-caso-de-covid-19
[4] Ministerio de Salud de Panamá. Decreto ejecutivo 504 [Internet]. Panama; 2020. p. 1-25. Available from: https://www.gacetaoficial.gob.pa/pdfTemp/28986_A/GacetaNo_28986a_20200323.pdf
[5] OPS. Reporte No. 46 - COVID-19 [Internet]. 2021. Available from: https://www.paho.org/es/documentos/covid-19-informe-situacion-panama-ndeg46-enero-26-2021
[6] Covid Performance - Lowy Institute [Internet]. [cited 2021 Mar 10]. Available from: https://interactives.lowyinstitute.org/features/covid-performance/#rankings
[7] Casaboza JC, Cárdenas DE. Analysis and Modeling of Dynamic Behavior of the COVID-19 Outbreak : Study Case of Panama. IEEE Lat Am Trans [Internet]. 2020 [cited 2021 Mar 11];19(6):893-900. Available from: https://latamt.ieeer9.org/index.php/transactions/article/view/4227 DOI: https://doi.org/10.1109/TLA.2021.9451233DOI: https://doi.org/10.1109/TLA.2021.9451233
[8] Franco D, Gonzalez C, Abrego LE, Carrera JP, Diaz Y, Caicedo Y, et al. Early transmission dynamics, spread, and genomic characterization of SARS-CoV-2 in Panama. Emerg Infect Dis [Internet]. 2021 Feb 1 [cited 2021 Mar 11];27(2):612-5. Available from: https://doi.org/10.3201/eid2702.203767 DOI: https://doi.org/10.3201/eid2702.203767DOI: https://doi.org/10.3201/eid2702.203767
[9] Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA [Internet]. 2020 Mar;323(11):1061-9. Available from: https://doi.org/10.1001/jama.2020.1585 DOI: https://doi.org/10.1001/jama.2020.1585DOI: https://doi.org/10.1001/jama.2020.1585
[10] Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan , China. Lancet [Internet]. 2020;395(10223):497-506. Available from: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30183-5/fulltext DOI: https://doi.org/10.1016/S0140-6736(20)30183-5DOI: https://doi.org/10.1016/S0140-6736(20)30183-5
[11] Ortiz-Brizuela E, Villanueva-Reza M, González-Lara MF, Tamez-Torres KM, Román-Montes CM, Díaz-Mejía BA, et al. Clinical and Epidemiological Characteristics of Patients Diagnosed With Covid-19 in a Tertiary Care Center in Mexico City: a Prospective Cohort Study. Rev Invest Clin. 2020;72(3):165-77. DOI: https://doi.org/10.24875/RIC.20000211DOI: https://doi.org/10.24875/RIC.20000211
[12] Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, Villamizar-Peña R, Holguin-Rivera Y, Escalera-Antezana JP, et al. Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel Medicine and Infectious Disease. 2020. DOI: https://doi.org/10.1016/j.tmaid.2020.101623DOI: https://doi.org/10.1016/j.tmaid.2020.101623
[13] Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting Characteristics, Comorbidities, and Outcomes among 5700 Patients Hospitalized with COVID-19 in the New York City Area. JAMA - J Am Med Assoc. 2020;
Licencia
Derechos de autor 2021 Infomedic Intl.Derechos autoriales y de reproducibilidad. La Revista RevCog es un ente académico, sin fines de lucro, que forma parte de la Sociedad Centroamericana de Ginecología y Obstetricia. Sus publicaciones son de tipo ACCESO GRATUITO y PERMANENTE de su contenido para uso individual y académico, sin restricción. Los derechos autoriales de cada artículo son retenidos por sus autores. Al Publicar en la Revista, el autor otorga Licencia permanente, exclusiva, e irrevocable a la Sociedad para la edición del manuscrito, y otorga a la empresa editorial, Infomedic International Licencia de uso de distribución, indexación y comercial exclusiva, permanente e irrevocable de su contenido y para la generación de productos y servicios derivados del mismo.
